Cytokinetics, Incorporated (CYTK) is trading at $41.72, up 11.25 percent or $4.22 during Wednesday's trading, with no apparent reason for the surge.
The stock opened at $42.01 and has moved within a range of $41.15 to $43.69 today, compared to a previous close of $37.50 on the Nasdaq. Trading volume has reached 2.95 million shares, nearly double the average of 1.65 million.
The stock's 52-week range is between $37.46 and $75.71.
For comments and feedback: editorial@rttnews.com